Deterioration after Guillain-Barré syndrome: recurrence, treatment-related fluctuation or CIDP?
Hadden
Robert D M
RD
Department of Neurology, King's College Hospital, Denmark Hill, London SE5 9RS, UK. robert.hadden@nhs.net
D020275:Guillain-Barre Syndrome / Q000276:immunology* / Q000628:therapy*; D006801:Humans; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000276:immunology* / Q000628:therapy*; D012008:Recurrence